BGAM
AGN

Boussard & Gavaudan Asset Management’s Allergan plc AGN Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,190
Closed -$266K – 88
2014
Q2 		$266K Sell
1,190
-1,360
-53% -$282K 0.13% 27
2014
Q1 		$519K Buy
+2,550
New +$505K 0.32% 6

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boussard & Gavaudan Asset Management's AGN Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Allergan plc (AGN) in Q3 2014, closing a stake of 1,190 shares — an estimated $266K sold.

Boussard & Gavaudan Asset Management first reported a position in AGN in Q1 2014 and held it in 2 quarters. The position peaked at $519K in Q1 2014. 753 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Allergan plc position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 1,190 Allergan plc shares in Q3 2014, an estimated $266K.
  • Boussard & Gavaudan Asset Management first reported a position in Allergan plc in Q1 2014 and held it in 2 quarters.
  • Boussard & Gavaudan Asset Management's Allergan plc position peaked at $519K in Q1 2014.
  • 753 funds tracked by Wall St. Rank held Allergan plc as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.